Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
One of the reasons they haven't announced (or had it), IMO. We are 83 days from 2 YEARS after data lock. It's just unbelievable.
Don't worry, the XBI is down....we're tied to that
MM manipulation and shorts
Long term play, have patience
Nov. 22nd is 8 months past last short-term financing note. As of August, we will be paying two significant payments each month, with little to no revenue. 10Q has to be out by August 15th. I would expect another financing soon, if not already in the works. Should have known LP's plan when the past financing 8k was posted...
"Upon announcement of the top line data (“TLD”) from the Company’s Phase III clinical trial of DCVax®-L for glioblastoma brain cancer, the Lender has a then-springing right to exchange the outstanding balance of the loan for common shares priced at the price of the first private placement transaction following TLD less a 12% discount and to purchase another 50% of that number of shares at the same price. This then-springing right expires 14 days after the post-TLD private placement."
Probably why THE COMPANY has not announced it.
Last week?
There has been a tremendous downside. Done properly, this would be a $10B market cap while awaiting publication and approvals. Juno/Kite, both with less to offer were far ahead and sold for large multiples of potential. The list of self-inflicted wounds here is long. When you have know-it-all lawyer running a public company in silence, what could go wrong?
And taking their plan as gospel won't help either. Common sense is a best practice too. So, Allowing outside presentations of partial data, while the self-imposed inability to respond and defend it is not smart. If the plan was still to release JA and TLD close together, NO presentations should have been made until they were ready. So, why isn't it ready? No takers for article? DI said they are still "currently pursuing a publication"? So, I would contend the "journal embargo" is self-imposed as well. I can be just a confident in my estimation as you can since they won't say where we are.
Journal embargo does not prevent TLD PR by company. It's self-imposed.
Right. Due to the self-imposed silence strategy.
Strong bid, little selling? Do we break through .82 and the 100DMA today or tomorrow?
So, again, I do not understand the cafeteria-style PR plan. they PR, although poorly, May 10th and ASCO....then nothing for Liverpool and nothing for Switzerland with LL finally presenting????
I don't get it.
I think we will see the same algo patterns today as the past few days. Watch to see if the heavy ask flips to the bid after lunch. if so, could pop .82 and hold.
Yup, they will pull the bid and wait for cheap shares and then bid it back up. Don't think this will be a FOMO friday but I do believe the trend is now in our favor short-term.
We are going to get hit this morning. The strength of the move will be determined by testing and retesting .82, IMO. If we get through it, it could be off to the races.
I think we will hold .80, but doubt we get through .82 today. That may be pretty tough. Two moving averages (50/100) and recent high of .82 will likely take a few tries.....but when it gets through, it could be a pretty big pop.
I am confident that the FULL results, and release, along with the journal article will put all that concern to rest. They CLEARLY have not shared all. There is no way in hell you would be spending time and money on production if you didn't feel approval was a lock. That is my frustration. If we could see and dissect all the data, and get it into the public eye, I believe DCVax would be a household name by now.
This is the SHIT that drives me crazy...
"Northwest Biotherapeutics has announced that an application for a manufacturing license for commercial manufacturing of cellular therapies (after the therapies receive regulatory approval) has been submitted to the regulatory authorities."
It doesn't even say NWBO submitted it? It was likely by Advent. So, they will break from the two year silence to let their shareholders know that Advent has submitted an application for cellular therapies, which, we are left to guess, are hopefully related to DCvax.
No, just more cart-before-the-horse spending. It's great, and again, we can GUESS that they hope to get approval. We all hope that. No TLD, No Journal, No notification of approval submissions, no ASM....but we are getting ready to manufacture?
Disagree with the strategy around data silence.
IF, it's always IF. Why can't they be honest and clear? there is no rule that prevents you from saying we HAVE submitted. We are "actively pursuing"?? Meaningless wordsmithing. Two months is a very, very long time under embargo if it's even true. And, no embargo prevents you from issuing a TLD PR.
I have seven plus years of patience. Patience for the trial, therapy and data were enough. I have no patience for nwbo leadership due to their lack of communication. They will speak about everything except the most important piece....the phase 3 results. There is no way in hell we are under a 2 month embargo. It's their choice, and they are wrong to be silent.
it will be interesting to see if the PR has an afternoon affect on this recent move up. It would be nice to see us get through .80 and hold.
Yup. As if questioning the policy of silence is idiotic. "The company" knows best. Says who? I have contended that it hasn't worked and would also contend that we could very likely be in a much better financial position (PPS and financing) if they would have been completely transparent throughout the entire process with very detailed and specific updates of where we are and what is happening.
Here Here.
Looks like we need to get to .82 to hit 50/100DMA, and the 100 is crossing the 50. This would also be the highest high since May 13th. RSI, MACD, All good trend technicals that could start the next gap up, IMO.
Working hard to hold this under .80, hopefully an afternoon push through.
10 minutes, no trades, who's going to ask? C'mon, you know who you are....
If it heads back to the high near .80 by EOD, then maybe we are in a trend reversal, if not, probably just a weekly FOMO for the ever-elusive journal article wed release expectation.
You just made my point, LOL. You, like everyone else, is down over a dollar per share since May. You can excuse it any way you like. XBI, the market, etc.
LMFAO, ok. The "quiet period" has been the strategy. Two years of failed strategy. LP is a dinosaur. This should have been on every television show, on every social media outlet, every potential way to get the word out. The forces against us need to be pushed, not feared. Doctors who resist change and immunotherapy in general. BP, who has a financial interest in squashing nwbo. The FDA and their antiquated methodologies and processes. All of these needed to be exposed from the start with irrefutable public info to force hands and expose the bad guys. This would be approved by now. Instead, we are irrelevant and unheard of. Instead we are at .70 with all the nefarious players winning.
Many permanent defenders here are the same who sit at a blackjack table and say that the $2,000 they lost was not lost, it was house money....I still have my original $100. This stock was, and should continue to be $2+ right now. The fact that it is .70 is 100% due to the poorly executed, poorly devised strategy.
Not likely a market mover, IMO. UNLESS....it's speculation that because they scheduled the ASM, then formal TLD and Journal are 100% going to happen prior to then.
Haven't closed over .72 in two months. Only two days trading over 2.5 million as well. DMI close to crossing green for the first time since May 10th. Interesting, but not confirming....yet.
Disagree. Any BP that is currently interested would be buying up to the SEC limits prior to having to file. At that point the PPS would be considerably higher anyway. The multiple would be dictated by the revenue and profit potential. Either way, 2x PPS at current price is not even close. This would be a 6-10X potential revenue multiple. This is "potential" buy, not a "multiple" buy. IMO. Look back at Juno and Kite acquisitions. $9-12B, one prior to phase 3 results and one after less than stellar phase 3 (I believe), with no revenue yet. I think NWBO, right now would sell for more than either of those (~$15-20B) on it's potential and patents and 20yrs of data. LP will not sell, IMO, until it is recognized that Direct can be used on most solid tumors, in which case, we are likely looking at $50+B.
Yes, ridiculous because the company refuses to defend shareholder's investment.
Immediate morning slam attempt starting. 77k on the ask at .63
This is ridiculous.
Manipulation to keep PPS stable and low for covering? Makes sense.
I doubt there are many swing traders in this stock, or as many short shares as people think. It's pretty easy to support the price here, just not get it to go up. I have put buys in for the past two days. 10,200 shares sitting at .64. If I move it to .65, they will likely move the bid to .66. I am sure I'm not the only one. So, the MM's try to put out as many shares as they can at .66-67, THEN they will come down to get more share to make their couple of pennies.
I am done with the conversations about quiet periods and embargoes. If there is a logical reason and timeframe, it should be known exactly what that is. period. They said it was to wait for TLD announcement and Journal. We have had neither in two years and no explanation of where we are, which would not jeopardize anything by saying so. I don't care who they are listening to, they are wrong.
I am more interested in connecting the dots of why LP, et.al. were in Liverpool. The conference was a rehash of NYAS with a small addition. Not necessary to travel with the group to be in person. I believe there must have been meetings with UK/MHRA. They have said multiple times that UK approval could come first, for a variety of reasons. Hoping that is closer than the journal.
Agreed. The problem is there is no known time frame. Appears endless, which is why we wither on the vine on route .66.
This is a new era in medicine. Pioneers break barriers. Lead from the front. Conventional wisdom and processes should be tossed and new mentalities should drive this. Not fear of the FDA and their traditional process, not fear of researchers and doctors and BP who will resist change. Scream from the rooftops and put the data out there and defend it to high heaven!
Conventional wisdom, by definition, is backwards thinking.....
"the best practice quiet period?" "Does not allow for the release of TLD?"
It's amazing if you actually believe your own words. The quiet period was self-imposed, so no "rules" to it. And, they claimed it would be in place until TLD, which they have, and have let others present, and yet they are still quiet. That is incompetence, lying and/or negligence, period. The new "embargo" while "seeking" a publication is also self-imposed unless a Journal has accepted the manuscript. And, even then, TLD is NOT something a Journal would prevent a company from PR'ing.
You have your opinion, it is just that, like everyone else's. However, your argument would not hold up in debate club.